2Zhang JW, Wang JY, Chen SJ, et al. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J Biosci ,2000,25 ( 3 ) :275-284.
3So CW, Dong S, So CK, et al. The impact of differential binding of wide-type RARalpha, PML-, PLZF-and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acide responses in acute promyelocytic leukemia. Leukemia, 2000,14 ( 1 ):77-83.
4Pendiuo F, Flexor M, Delhommeau F, et al. Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukemia. Proc Natl Acad Sci USA,2001,98(12) :6662-6667.
5Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol,2001,38( 1 ) :13-25.
6Cai X, Shen YL, Zhu Q, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmemnbrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia, 2000,14 ( 2 ): 262 -270.
7Di Noto R, Boccuni P, Costantini S, et al. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family. Tissue Antigens. 1999,54(6) :597-602.
8Gianni M, Koken MH, Chelbi-Alix MK, et al. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistent NB4 cells. Blood, 1998,91 ( 11 ) :4300-4310.
9Petti MC, Fazi F, Gentile M, et al. Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia:in vitro and in vivo studies . Blood, 2002, 100 (3):1065-1067.
10Cote S, Rosenauer A, Bianchini A, ct al. Response to histonc deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid- resistent APL cells. Blood,2002,100 ( 7 ) :2586-2596.
